Stay updated on Psilocybin for MDD: Novel Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.

Latest updates to the Psilocybin for MDD: Novel Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record for the psilocybin trial for major depressive disorder is now displayed, including its design, eligibility criteria, outcomes, locations, results-posting status, and study documents.SummaryDifference65%

- Check15 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe revision number in the footer changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header (including a 403 label and a Home button) and a revision notice, replacing the normal study details and links with an error screen. This indicates an access issue rather than an update to the study record.SummaryDifference20%

Stay in the know with updates to Psilocybin for MDD: Novel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.